LAURREN BENNETT: Open Payments
NPI 1104419431 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,140 in 59 payments from 20 companies in 2025. Trend: 2023 $39 · 2024 $711 · 2025 $1,140
Food & beverage: $1,140
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $160 |
| Astellas Pharma US Inc | 6 | $140 |
| Antares Pharma, Inc. | 7 | $122 |
| Vanda Pharmaceuticals Inc. | 3 | $97 |
| Phathom Pharmaceuticals, Inc. | 5 | $88 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| Amgen Inc. | 4 | $62 |
| Aimmune Therapeutics, Inc. | 3 | $61 |
| Novo Nordisk Inc | 3 | $53 |
Products named: Veozah, XYOSTED, FANAPT, VOQUEZNA, VRAYLAR, REXULTI, TRELEGY ELLIPTA, EVENITY.
Industry payments across ID — which companies pay providers there.
